Sunshine Biopharma settles mutual release with former CEO Chamoun
Sunshine Biopharma and subsidiary Nora Pharma have settled all claims with former CEO Malek Chamoun following a mutual release agreement. The full settlement resolves complex legal issues surrounding the executive's termination, potentially reducing future financial and reputational risks for the companies.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day